How is the Xilio Therapeutics Inc today?

The Xilio Therapeutics Inc today is trading in the green, up by 7.14% at 0.90.

What is Xilio Therapeutics Inc Annual Net Profit?

Xilio Therapeutics Inc Annual Net Profit rose 23.77% in the last year to $58.24 M. Its sector's average net profit growth for the last fiscal year was -11.13%.

What is Xilio Therapeutics Inc Price to Earning Ratio?

Xilio Therapeutics Inc Price to Earning Ratio is -0.86, which is negative.

What is Xilio Therapeutics Inc Stock Price?

Xilio Therapeutics Inc Stock Price fell 25% and underperformed its sector by 36.54% in the past year.

What is Xilio Therapeutics Inc Quarterly Net profit?

Xilio Therapeutics Inc Quarterly Net profit rose 22.89% YoY to $13.26 M. Its sector's average net profit growth YoY for the quarter was -212.2%.

What is Xilio Therapeutics Inc Debt to Equity Ratio?

Xilio Therapeutics Inc Debt to Equity Ratio of 0.46 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Xilio Therapeutics Inc Return on Equity(ROE)?

Xilio Therapeutics Inc Return on Equity(ROE) for the last financial year was -214.02%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Xilio Therapeutics Inc Mutual Fund Holding?

Xilio Therapeutics Inc Mutual Fund Holding increased by 0.49% in the last quarter to 4.03.

What is Xilio Therapeutics Inc Institutional Holding?

Xilio Therapeutics Inc Institutional Holding increased by 0.98% in the last quarter to 34.8.

Xilio Therapeutics Inc XNAS: XLO

Xilio Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Xilio Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Xilio Therapeutics Inc
Rating: 1.66258325
Author: Trendlyne DVM scores

about

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effe...

0.90 0.06 (7.14%)

47.06% Fall from 52W High

292.3K XNAS Volume

XNAS 22 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

14.8 / 100

Technically Neutral

51.7 / 100

No estimates available

Xilio Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Xilio Therapeutics Inc FAQ

How is Xilio Therapeutics Inc today?

Xilio Therapeutics Inc today is trading in the green, and is up by 7.14% at 0.90.

How has Xilio Therapeutics Inc performed historically?

Xilio Therapeutics Inc is currently trading up 7.14% on an intraday basis. In the past week the stock rose 5.88%. stock has been down -3.23% in the past quarter and fell -25.00% in the past year. You can view this in the overview section.